Initiator Pharma A/S (STO: INIT)
Sweden
· Delayed Price · Currency is SEK
6.80
-0.10 (-1.45%)
Dec 20, 2024, 5:29 PM CET
Initiator Pharma Statistics
Total Valuation
Initiator Pharma has a market cap or net worth of SEK 382.46 million. The enterprise value is 364.29 million.
Market Cap | 382.46M |
Enterprise Value | 364.29M |
Important Dates
The last earnings date was Friday, November 29, 2024.
Earnings Date | Nov 29, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Initiator Pharma has 56.24 million shares outstanding. The number of shares has increased by 4.53% in one year.
Current Share Class | n/a |
Shares Outstanding | 56.24M |
Shares Change (YoY) | +4.53% |
Shares Change (QoQ) | +2.14% |
Owned by Insiders (%) | 9.35% |
Owned by Institutions (%) | 12.01% |
Float | 36.53M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 15.96 |
P/TBV Ratio | 16.01 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -22.55 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.79
Current Ratio | 11.79 |
Quick Ratio | 11.79 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -83.61% and return on invested capital (ROIC) is -49.03%.
Return on Equity (ROE) | -83.61% |
Return on Assets (ROA) | -45.17% |
Return on Capital (ROIC) | -49.03% |
Revenue Per Employee | n/a |
Profits Per Employee | -5.39M |
Employee Count | 3 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.60% in the last 52 weeks. The beta is 0.75, so Initiator Pharma's price volatility has been lower than the market average.
Beta (5Y) | 0.75 |
52-Week Price Change | -25.60% |
50-Day Moving Average | 7.04 |
200-Day Moving Average | 8.30 |
Relative Strength Index (RSI) | 43.01 |
Average Volume (20 Days) | 34,466 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | -17.90M |
Operating Income | -24.39M |
Pretax Income | -23.49M |
Net Income | -16.16M |
EBITDA | n/a |
EBIT | -24.39M |
Earnings Per Share (EPS) | -0.30 |
Balance Sheet
Cash & Cash Equivalents | 18.17M |
Total Debt | n/a |
Net Cash | 18.17M |
Net Cash Per Share | 0.32 |
Equity (Book Value) | 23.88M |
Book Value Per Share | 0.43 |
Working Capital | 23.86M |
Cash Flow
Operating Cash Flow | -17.13M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Initiator Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.53% |
Shareholder Yield | -4.53% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |